Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jan 31, 2025 | (Q2)Jul 31, 2024 | (Q1)Apr 30, 2024 | (FY)Jan 31, 2024 | (Q4)Jan 31, 2024 | (Q3)Oct 31, 2023 | (Q2)Jul 31, 2023 | (Q1)Apr 30, 2023 | (FY)Jan 31, 2023 | (Q4)Jan 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 2.08%32.78B | 0.40%7.9B | 2.48%8.03B | 1.80%32.11B | 0.62%8.58B | 1.45%7.83B | 2.56%7.87B | 2.70%7.83B | 6.11%31.54B | 2.78%8.52B |
| Cost of revenue | 3.56%20.13B | 2.98%4.92B | 3.34%4.85B | -0.12%19.44B | -0.11%5.21B | -0.20%4.76B | 0.06%4.78B | -0.22%4.69B | 4.21%19.46B | 1.04%5.21B |
| Gross profit | -0.18%12.65B | -3.60%2.98B | 1.19%3.18B | 4.89%12.67B | 1.78%3.37B | 4.13%3.07B | 6.68%3.09B | 7.42%3.14B | 9.32%12.08B | 5.65%3.31B |
| Operating expense | 3.52%11.17B | 1.45%2.74B | 2.36%2.69B | 2.03%10.79B | 2.74%2.78B | 1.58%2.69B | 1.56%2.7B | 2.24%2.63B | 6.72%10.58B | 1.68%2.7B |
| Operating profit | -21.42%1.47B | -38.91%236.21M | -4.79%486.98M | 25.05%1.88B | -2.52%592.32M | 26.17%386.02M | 64.73%386.68M | 45.17%511.46M | 32.06%1.5B | 27.80%607.65M |
| Net non-operating interest income (expenses) | -3.88%15.76M | 32.61%4.52M | 92.64%3.01M | 138.33%16.4M | 36.24%5.89M | 231.24%5.54M | 317.01%3.41M | 2,231.34%1.56M | 2,742.56%6.88M | 18,900.00%4.32M |
| Non-operating interest income | 13.26%18.91M | 31.31%4.55M | 81.58%3.03M | 125.80%16.7M | 33.16%5.92M | 214.56%5.64M | 265.05%3.47M | 717.16%1.67M | 908.87%7.4M | 2,733.12%4.45M |
| Non-operating interest expense | 940.59%3.15M | -40.98%36K | -82.86%18K | -41.28%303K | -74.19%32K | -13.93%105K | -54.14%61K | -23.36%105K | 5.09%516K | -31.11%124K |
| Net investment income | 192.60%1.7M | -70.01%581K | 0 | -99.82%1K | -1.07%1.94M | 0 | ||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 148.86M | 30.64M | 0 | 0 | |||||
| Income from associates and other participating interests | 3,634.27%141.8M | -32.46%26.71M | 139.38%23.97M | 91.50%-4.01M | 151.33%17.24M | 100.44%63K | 130.91%39.55M | -269.62%-60.87M | -145.90%-47.19M | -349.78%-33.59M |
| Special income (charges) | 75.66%-15.35M | 77.41%-4.9M | 308.11%1.9M | 25.52%-63.07M | 72.08%-37.74M | -641.52%-2.71M | -207.04%-21.7M | -103.07%-912K | -130.26%-84.67M | -206.15%-135.19M |
| Less:Other special charges | 96.02%10.75M | 166.95%953K | -308.11%-1.9M | 104.45%5.48M | -29.42%2.07M | 124.35%2.14M | 100.41%357K | 103.07%912K | 75.29%-123.24M | 101.89%2.93M |
| Less:Write off | -92.00%4.61M | ---- | ---- | -72.30%57.59M | -73.03%35.67M | -93.13%570K | ---- | ---- | -5.02%207.91M | -33.53%132.25M |
| Other non-operating income (expenses) | 4.33%41.58M | -37.59%2.72M | 0.79%19.06M | -9.96%39.85M | -33.78%2.84M | 0.78%13.74M | -39.08%4.37M | -1.40%18.91M | -33.45%44.26M | -61.65%4.28M |
| Income before tax | -17.62%1.66B | -35.65%265.7M | 13.78%534.92M | 41.72%2.02B | 36.59%611.19M | 69.08%520.87M | 47.11%412.88M | 21.91%470.15M | -10.45%1.42B | -1.85%447.48M |
| Income tax | -17.37%561.18M | -22.84%104.25M | 4.70%181.28M | 26.92%679.16M | 16.74%194.71M | 48.79%176.2M | 60.95%135.11M | 4.34%173.14M | -13.01%535.09M | -3.57%166.79M |
| Net income | -17.75%1.1B | -41.88%161.45M | 19.07%353.64M | 50.65%1.34B | 48.38%416.49M | 81.76%344.67M | 41.21%277.77M | 35.17%297.01M | -8.82%886.76M | -0.79%280.69M |
| Net income continuous operations | -17.75%1.1B | -41.88%161.45M | 19.07%353.64M | 50.65%1.34B | 48.38%416.49M | 81.76%344.67M | 41.21%277.77M | 35.17%297.01M | -8.82%886.76M | -0.79%280.69M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -17.75%1.1B | -41.88%161.45M | 19.07%353.64M | 50.65%1.34B | 48.38%416.49M | 81.76%344.67M | 41.21%277.77M | 35.17%297.01M | -8.82%886.76M | -0.79%280.69M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -17.75%1.1B | -41.88%161.45M | 19.07%353.64M | 50.65%1.34B | 48.38%416.49M | 81.76%344.67M | 41.21%277.77M | 35.17%297.01M | -8.82%886.76M | -0.79%280.69M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -17.41%163.94 | -41.82%24.01 | 19.17%52.59 | 50.65%198.5 | 48.38%61.89 | 81.79%51.21 | 41.19%41.27 | 35.16%44.13 | -8.82%131.76 | -0.78%41.71 |
| Diluted earnings per share | -17.41%163.94 | -41.83%24.0066 | 19.17%52.59 | 50.65%198.5 | 48.39%61.883 | 81.78%51.2084 | 41.21%41.2694 | 35.16%44.13 | -8.82%131.76 | -0.79%41.7031 |
| Dividend per share | 13.33%34 | 0 | 0 | 25.00%30 | 25.00%30 | 0 | 0 | 0 | 0.00%24 | 0.00%24 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |